| アブストラクト | Differences in effectiveness between haloperidol injection and oral atypical antipsychotics in the acute-phase treatment of schizophrenia are not well examined. We retrospectively investigated whether these treatment options affected the length of mechanical restraint. We used the Japanese Diagnosis Procedure Combination Database to identify schizophrenia patients who were involuntarily hospitalized and receiving mechanical restraint between July and December, 2006-2009. Data included patient demographics, use of antipsychotics, and number of days on which patients underwent mechanical restraint. Propensity score matching was performed to compare the number of days of mechanical restraint between the haloperidol injection group and the oral atypical antipsychotics group. We used survival analysis to examine whether the initial difference in treatment affected the number of days of mechanical restraint. Cox regression was performed to compare the concurrent effects of various factors. Among 1731 eligible patients, 574 were treated with haloperidol injections and 420 with atypical antipsychotics. Matching produced 274 patients in each group. Cox regression analysis showed that the initial therapeutic agents did not significantly affect the number of days of mechanical restraint. The results indicate that atypical antipsychotics were as effective as haloperidol injections in the acute-phase treatment of schizophrenia. |
|---|
| ジャーナル名 | Psychiatry research |
|---|
| Pubmed追加日 | 2013/03/16 |
|---|
| 投稿者 | Nakamura, Mitsuhiro; Yasunaga, Hideo; Haraguchi, Tadashi; Ando, Shuntaro; Sugihara, Toru; Horiguchi, Hiromasa; Ohe, Kazuhiko; Matsuda, Shinya; Fushimi, Kiyohide |
|---|
| 組織名 | Department of Psychiatry, Yokohama Camellia Hospital, Kanagawa, Japan; Department;of Mental Health, Graduate School of Medicine, The University of Tokyo, Tokyo,;Japan. Electronic address: michongjr@m.u-tokyo.ac.jp. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/23489593/ |
|---|
